This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.
The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to
About the Federal Register
on NARA's archives.gov.
The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.
Notice
Enter a search term or FR citation e.g.
88 FR 38230 FR 78782024-13208USDA09/05/24RULE0503-AA39SORN
Choosing an item from
full text search results
will bring you to those results. Pressing enter in the search box
will also bring you to search results.
Choosing an item from
suggestions
will bring you directly to the content.
This table of contents is a navigational tool, processed from the
headings within the legal text of Federal Register documents.
This repetition of headings to form internal navigation links
has no substantive legal effect.
Document page views are updated periodically throughout the day and are
cumulative counts for this document. Counts are subject to sampling,
reprocessing and revision (up or down) throughout the day.
Page views
35
as of
07/21/2026 at 12:15 am EDT
Other Formats
Enhanced Content - Other Formats
This document is also available in the following formats:
This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.
AGENCY:
Food and Drug Administration, HHS.
ACTION:
Notice of public conference.
SUMMARY:
The Food and Drug Administration (FDA), Cincinnati District, in co-sponsorship with Xavier University, is announcing a public conference entitled “FDA/Xavier University Global Outsourcing Conference.” This 3-day public conference for the pharmaceutical industry includes presentations from key FDA officials, global regulators, and industry experts. The conference will focus on global compliance challenges associated with pharmaceutical outsourcing relationships and supply chain control, as well as expectations from global regulators. Pharmaceutical companies and contract organizations are invited to this conference to address the issues that reside on both sides. In addition to expert presentations, participants will be engaged through live polling and a small group discussion session on sharing best practices with each other.
Dates and Times: The public conference will be held on June 14 and 15, 2010, from 8 a.m. to 5 p.m. and June 16, 2010, from 8 a.m. to 1 p.m.
Location: The public conference will be held on the campus of Xavier
( printed page 22413)
University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745-3073 or 513-745-3396.
Contact Persons:
For information regarding this notice: Steven Eastham, Food and Drug Administration, 6751 Steger Dr., Cincinnati, OH 45237, 513-679-2700, ext. 123, e-mail:
steven.eastham@fda.hhs.gov.
For information regarding the conference and registration: Marla Phillips, Xavier University, 3800 Victory Pkwy., Cincinnati, OH 45207, 513-745-3073, e-mail:
phillipsm4@xavier.edu.
Registration: There is a registration fee. The conference registration fees cover the cost of the presentations, training materials, receptions, breakfasts, lunches, dinners, and dinner speakers for the 3 days of the conference. Early registration ends May 14, 2010. Standard registration ends June 13, 2010. There will be onsite registration. The cost of registration is as follows:
Table 1.—Registration Fees1
Attendees
Fees by May 14th
Fees by June 13th
Industry
$995
$1,200
Small Business (< 100 employees)
$800
$1,000
Academic/Government
$600
$700
Student
$200
$250
FDA Employee
Fee waived
Fee waived
1
The fourth registration from the same company is free.
The following forms of payment will be accepted: American Express, Visa, Mastercard, and company checks.
To register online for the public conference, please visit the “Registration” link on the conference Web site at
http://www.XavierGOC.com. (FDA has verified the Web site address, but is not responsible for subsequent changes to the Web site after this document publishes in the
Federal Register
.)
To register by mail, please send your name, title, firm name, address, telephone and fax numbers, e-mail, and payment information for the fee to Xavier University, Attn: Sue Bensman, 3800 Victory Pkwy., Cincinnati, OH 45207. An e-mail will be sent confirming your registration.
Attendees are responsible for their own accommodations. The conference headquarter hotel is the Downtown Cincinnati Hilton Netherlands Plaza, 35 West 5th Street, Cincinnati, OH 45202, 513-421-9100. To make reservations online, please visit the “Venue/Logistics” link at
http://www.XavierGOC.com.
If you need special accommodations due to a disability, please contact Marla Phillips (see
Contact Persons) at least 7 days in advance of the conference.
SUPPLEMENTARY INFORMATION:
The public conference helps fulfill the Department of Health and Human Services and FDA's important mission to protect the public health. The conference will provide those engaged in FDA-regulated outsourcing with information on the following topics:
FDA Center to present on initiatives from Congress and FDA, and resulting impact;
Global regulator perspective on global compliance initiatives, challenges, and expectations;
FDA Field perspective on the most common and significant deficiencies specific to outsourcing relationships;
Global compliance of manufacturing in Asia;
Pharmaceutical companies—how to manage varying global regulatory expectations while working with contractors in various states of compliance;
Contract organizations—compliance strategy for managing global regulatory requirements while managing multiple client expectations;
Contract Organization Selection Process;
The Client Selection Process—the criteria a contract organization should use to consider saying no to a contract relationship;
Regulatory challenges—Drug Master File Fitness;
Due diligence audit—how to audit in 1 day;
Quality Agreement Development throughout the product and process lifecycle;
Supply Chain Transparency and Pedigree;
How to Audit the Supply Chain;
Rx-360 and International Pharmaceutical Excipients Council initiatives—impact to industry;
Risk-based Performance Management best practices;
International Conference on Harmonisation Triple Q's (Q8, Q9, and Q10)—how quality can drive down the cost of business, and how innovation can increase business opportunities;
Rebuilding the Trust case studies; and
Small group discussion on sharing best practices.
FDA has made education of the drug and device manufacturing community a high priority to help ensure the quality of FDA-regulated drugs and devices. The conference helps to achieve objectives set forth in section 406 of the Food and Drug Administration Modernization Act of 1997 (21 U.S.C. 393), which includes working closely with stakeholders and maximizing the availability and clarity of information to stakeholders and the public. The conference also is consistent with the Small Business Regulatory Enforcement Fairness Act of 1996 (Public Law 104-121) by providing outreach activities by Government agencies to small businesses.